Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3Wei Xie(Institute for Infocomm Research), Ying Leng(Chinese Academy of Sciences)Frontiers in PharmacologyMay 15, 201810.3389/fphar.2018.00476Cited by 25SaveCiteExport RISWatch citationsRelated PapersAlisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice|Nutrients|2022|41SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice|Acta Pharmacologica Sinica|2021|15